Actelion to discuss Half Year financial results 2009>
Actelion to discuss Half Year financial results 2009
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Actelion senior management to host Q & A sessionDear Member of the Investment CommunityActelion Ltd will announce the Half Year financial results 2009 onTuesday, 21 July 2009, at 07.00 hrs CEST / 06.00 hrs BST / 01.00 a.m.EDT. An investor conference call & webcast will be held at 15.30 hrs,CEST to discuss the results.In addition, the company will provide a comprehensive update on itsclinical development pipeline.To discuss the results, Actelion will host an Investor ConferenceCall / Webcast as follows:Date/Time:21 July 2009 15.30 hrs - 16.30 hrs Basel (CEST) 14.30 hrs - 15.30 hrs U.K. (BST) 09.30 a.m. - 10.30 a.m. U.S. (EDT)Conference Call Connect #:Dial-in participants should start calling the number below 10-15minutes before the Conference is due to start.Dial: Europe: +41 44 580 64 03 U.K.: +44 203 147 47 52 U.S.: +1 866 931 15 72Participant's mode:Listen-Only with possibility to open individual lines during Q&Asession.Participants will be asked for their Name and Company.Webcast Access:Webcast participants should visit the Actelion websitehttp://www.actelion.com 10-15 minutes before the conference is due tostart. If you experience any access problems go directly to the URL:http://gaia.world-television.com/actelion/20090721/truncParticipant's mode:Listen-Only with possibility to ask individual questions by clickingon the Q&A button.Participants will be asked to provide their Name and Company.Webcast Replay:The archived Investor Webcast will be available for replay throughhttp://www.actelion.com/approximately 60 minutes after the call has ended.http://hugin.info/131801/R/1329018/313571.pdf --- End of Message ---Actelion Pharmaceuticals LtdGewerbestrasse 16 Allschwil SwitzerlandWKN: 936767; ISIN: CH0010532478; Index: SBIOM, SLIFE, SMCI, SMIEXP, SMIM, SPI, SPIEX;Listed: Main Market in SIX Swiss Exchange;
Bereitgestellt von Benutzer: hugin
" alt="Second Quarter 2009 Results>">
" alt="Interim Management Statement>">Datum: 15.07.2009 - 17:35 Uhr
Sprache: Deutsch
News-ID 3598
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 338 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Actelion to discuss Half Year financial results 2009>"
steht unter der journalistisch-redaktionellen Verantwortung von
Actelion Pharmaceuticals Ltd (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
